KYNB - FIBROGEN INC

6.84
-0.045   -0.658%

Share volume: 54,751
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.14%

PREVIOUS CLOSE
CHG
CHG%
$6.88
-0.04
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Report Date 05-06-2024 08-06-2024 11-12-2024 03-17-2025 05-12-2025 08-11-2025 11-10-2025
Total revenue 55.902 M 50.641 M 46.333 M -123.255 M 2.739 M 1.348 M 1.076 M
Cost of revenue 25.753 M 5.178 M 5.295 M -20.665 M 252.000 K 85.000 K -58.000 K
Gross profit 30.149 M 45.463 M 41.038 M -102.590 M 2.487 M 1.263 M 1.134 M
    50.79% -9.73% -349.99% 102.42% -49.22% -10.21%  
Operating expenses 61.212 M 56.382 M 39.262 M -11.834 M 17.281 M 12.922 M 6.504 M
Selling general and admin 22.820 M 22.276 M 17.554 M -13.320 M 8.106 M 7.057 M 5.295 M
Research and development 38.392 M 34.106 M 21.708 M 1.486 M 9.175 M 5.865 M 1.209 M
Total expenses 61.212 M 56.382 M 57.816 M -10.934 M 17.407 M 13.315 M 6.545 M
    -7.89% 2.54% -118.91% 259.20% -23.51% -50.84%  
Operating income -31.063 M -10.919 M -16.778 M -91.656 M -14.920 M -12.052 M -5.411 M
Ebit -28.493 M -12.200 M -12.976 M -91.451 M -14.507 M -11.766 M -4.480 M
Pretax income -33.489 M -16.983 M -17.970 M -84.925 M -16.764 M -13.775 M -13.146 M
    -49.29% 5.81% 372.59% -80.26% -17.83% -4.57%  
Income tax 33.000 K -262.000 K 12.000 K -52.000 K 2.000 K -92.000 K 0.000
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -32.933 M -15.544 M -17.084 M 17.982 M 4.639 M -7.603 M 200.636 M
    52.80% -9.91% 205.26% -74.20% -263.89% 2,738.91%